chrX-18945140-G-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000292.3(PHKA2):c.556C>T(p.Arg186Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000926 in 1,079,675 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000292.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.26e-7 AC: 1AN: 1079675Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 346697
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Glycogen storage disease IXa1 Pathogenic:2
PHKA2 NM_000292.2 exon 6 p.Arg186Cys (c.556C>T): This variant has been reported in the literature in at least 2 individuals with Glycogen storage disease IX (also described as X-Linked Liver Glycogenosis) (Hendrickx 1996 PMID:8733133, Davit-Spraul 2011 PMID:21646031). This variant is not present in large control databases. This variant is present in ClinVar (Variation ID:10538). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. Other variants at this same codon (p.Arg186His, p.Arg186Pro) have been reported in the literature, supporting that this region has significance. In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant classified as likely pathogenic. -
This variant has been observed in several individuals with clinical features of glycogen storage disease (PMID: 8733133, 10330341, Invitae). ClinVar contains an entry for this variant (Variation ID: 10538). This sequence change replaces arginine with cysteine at codon 186 of the PHKA2 protein (p.Arg186Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Arg186 amino acid residue in PHKA2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8733134, 9835437, 25266922). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Glycogen storage disease IXa2 Pathogenic:1
- -
not provided Pathogenic:1
Observed in the hemizygous state in several unrelated patients with features of a PHKA2-related disorder referred for genetic testing at GeneDx and in the published literature (Hendrickx et al., 1996; Hendrickx et al., 1999; Davit-Spraul et al., 2011) A different missense change at this residue (R186H) has been reported as likely pathogenic in ClinVar (SCV000898874.1; Landrum et al., 2016) Not observed in large population cohorts (Lek et al., 2016) In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at